Home / Business and Economy / Neuberg Diagnostics eyes $400M IPO in 2028
Neuberg Diagnostics eyes $400M IPO in 2028
7 Jul
Summary
- Company plans IPO in fiscal year 2028 aiming to raise ₹3,500-4,000 crore.
- A pre-IPO funding round seeks ₹500 crore for acquisitions and expansion.
- Neuberg aims to become the second-largest player in the diagnostics market.
Neuberg Diagnostics is preparing for a substantial initial public offering (IPO) targeted for fiscal year 2028, with plans to raise between ₹3,500 crore and ₹4,000 crore. This offering is anticipated to occur between April and September of that year, depending on market conditions. The company also aims to raise ₹500 crore in a pre-IPO funding round within the next three to six months.
This pre-IPO capital infusion is earmarked for acquiring four to five businesses as part of a pan-India expansion strategy. Neuberg Diagnostics specializes in new-generation diagnostic technologies, including genomics testing and longevity programs. The company forecasts that revenue from these advanced tests will increase from 15% to 25% within three years.
Neuberg Diagnostics reported a gross revenue of ₹1,400 crore in FY26. The company is focusing its immediate expansion efforts on key regions such as Mumbai, Maharashtra, Delhi, and the NCR region. With these strategic moves, Neuberg aims to position itself as the second-largest player in the competitive diagnostics market.
